Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Iaso Therapeutics Inc.

Headquarters: East Lansing, MI, United States of America
Year Founded: 2018
Status: Private

BioCentury | Nov 9, 2023
Deals

China’s strength is innovation on innovation. Western partners are lining up

Deep antibody expertise is a platform for leaps in new assets and technologies as Asia biotechs become increasingly competitive
BioCentury | Oct 5, 2023
Product Development

Innovation in autoimmune CAR Ts doesn’t stop at CD19

Dual targeting, allogeneic designs and novel targets are all under investigation to help CAR T cells reach more autoimmune patients
BioCentury | Jan 27, 2023
Finance

Jan. 26 Quick Takes: Grey Wolf bringing neoantigen-booster to the clinic with $49M B round

Plus: Keytruda approved for adjuvant NSCLC and updates for AZ’s Evusheld, BMS’s Breyanzi, Magenta, Theonys and more
Items per page:
1 - 3 of 3